Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in mice.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Immunopharmacology

• Publication date

  2009-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.intimp.2009.08.002PMID 19671449
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-gamma production by mouse activated T lymphocytes.

  2009cited by this paper
• Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte.

  2009cited by this paper
• Phosphodiesterase 7A inhibitor ASB16165 suppresses proliferation and cytokine production of NKT cells.

  2009cited by this paper
• Interleukin‐4 induces human hepatocyte apoptosis through a Fas‐independent pathway

  2007cited by this paper
• IL-6 Prevents T Cell-Mediated Hepatitis via Inhibition of NKT Cells in CD4+ T Cell- and STAT3-Dependent Manners

  2004cited by this paper
• Phosphodiesterase 7A-Deficient Mice Have Functional T Cells

  2003cited by this paper
• Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes

  2002cited by this paper
• Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling.

  2002cited by this paper
• Lethal Hepatitis After Gene Transfer of IL-4 in the Liver Is Independent of Immune Responses and Dependent on Apoptosis of Hepatocytes: A Rodent Model of IL-4-Induced Hepatitis1

  2001cited by this paper
• TNF-α-Induced Expression of Adhesion Molecules in the Liver Is Under the Control of TNFR1—Relevance for Concanavalin A-Induced Hepatitis1

  2001cited by this paper
• Cyclic nucleotide phosphodiesterases: relating structure and function.

  2001cited by this paper
• NKT cells: facts, functions and fallacies.

  2000cited by this paper
• Critical contribution of liver natural killer T cells to a murine model of hepatitis.

  2000cited by this paper
• Augmentation of Vα14 Nkt Cell–Mediated Cytotoxicity by Interleukin 4 in an Autocrine Mechanism Resulting in the Development of Concanavalin a–Induced Hepatitis

  2000cited by this paper
• Importance of Kupffer cells for T-cell-dependent liver injury in mice.

  2000cited by this paper
• CD3- and CD28-dependent induction of PDE7 required for T cell activation.

  1999cited by this paper
• Cytokines in Viral Hepatitis

  1999cited by this paper
• Pathogenesis of autoimmune hepatitis.

  1999cited by this paper
• The molecular biology of cyclic nucleotide phosphodiesterases.

  1999cited by this paper
• Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.

  1997cited by this paper
• In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis

  1997cited by this paper
• Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-κB

  1997cited by this paper
• T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6

  1994cited by this paper
• Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae.

  1993cited by this paper
• A T cell-dependent experimental liver injury in mice inducible by concanavalin A.

  1992cited by this paper

• Discovery of novel pyrrolopyrimidine-based PDE7 inhibitors against alcoholic liver injury

  2025cites this paper
• Advances in the development of phosphodiesterase 7 inhibitors.

  2023cites this paper
• Pharmacokinetic/Pharmacodynamic Assessment of Selective Phosphodiesterase Inhibitors in a Mouse Model of Autoimmune Hepatitis

  2022cites this paper
• Pharmacokinetic/Pharmacodynamic Evaluation of a New Purine-2,6-Dione Derivative in Rodents with Experimental Autoimmune Diseases

  2022cites this paper
• PK/PD Modeling of the PDE7 Inhibitor—GRMS-55 in a Mouse Model of Autoimmune Hepatitis

  2021cites this paper
• Long non-coding RNA HOTAIR knockdown alleviates lipopolysaccharide-induced acute respiratory distress syndrome and the associated inflammatory response by modulating the microRNA-30a-5p/PDE7A axis.

  2021cites this paper
• Long non ‐ coding RNA HOTAIR knockdown alleviates lipopolysaccharide ‐ induced acute respiratory distress syndrome and the associated inflammatory response by modulating the microRNA ‐ 30 a ‐ 5 p / PDE 7 A axis

  2021cites this paper
• From Diospyros kaki L. (Persimmon) Phytochemical Profile and Health Impact to New Product Perspectives and Waste Valorization

  2021cites this paper
• Comparative Assessment of the New PDE7 Inhibitor – GRMS-55 and Lisofylline in Animal Models of Immune-Related Disorders: A PK/PD Modeling Approach

  2020cites this paper
• New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases.

  2020cites this paper
• Concanavalin-A as a Model for Induction of Murine Autoimmune Hepatitis: Role of TNF-α and NF-κβ During The Acute Phase.

  2020cites this paper
• Recent advanced in bioactive systems containing pyrazole fused with a five membered heterocycle.

  2015cites this paper
• Recent Advances in the Development of PDE7 Inhibitors

  2014cites this paper
• CHAPTER 1 cAMP-Specific Phosphodiesterases : Modulation , Inhibition , and Activation

  2012cites this paper
• cAMP‐Specific Phosphodiesterases: Modulation, Inhibition, and Activation

  2012cites this paper